Table 5.

Relationship between SAA3, CRP3, L3, SAA3/L3 levels and patient outcome at composite endpoint (M±SD).

Outcome	N	SAA3	CRP3	L3	SAA3/L3
Discharge	51	11.02±26.83	2.52±3.61	1.43±0.41	8.60±21.79
Improved	27	27.67±51.41	10.46±18.68	1.39±1.05	35.45±87.47
Exacerbation	5	121.40±107.63	92.06±85.11	0.83±0.61	195.60±201.66
Death	11	169.82±52.85	79.92±58.15	0.44±0.29	540.24±351.73
Total	94	40.26±69.13	18.62±40.94	1.27±0.73	88.47±215.68
H		37.412	38.405	29.919	38.280
p		0.000	0.000	0.000	0.000